InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-6.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Verwiel Frank, Director. Officer active across 1 company, notably Intellia Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €35k. Activity tracked since 23 June 2021. The latest transaction was filed on 17 June 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
1,505 shares@ US$25.00100.0% of flowCommon StockSEC:0000950170-24-075718:0
7,737 shares0Common StockSEC:0000950170-24-073704:0
4,425 shares0Common StockSEC:0001209191-23-037898:0
5,197 shares0Common StockSEC:0001209191-22-037604:0
2,094 shares0Common StockSEC:0001209191-21-043385
2,094 shares0Common StockSEC:0001209191-21-043385:0
6 of 6 declarations
About Verwiel Frank
Frank Verwiel is a Board Member at Intellia Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
